Frontlight ResearchEarly access
CompletedPhase 4
Erector Spinae Plane Block Vs. IPACK Block with Adductor Canal Block for Total Knee Arthroplasty
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 90 people enrolled
- Started
- 30 Mar 2024
- Ended
- 20 Aug 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Control Test - spinal anesthesia
- Ropivacaine 0.2% Injectable Solution ESPB
- Ropivacaine 0.2% Injectable Solution iPACK+ACB
- Record updated
- 26 September 2024
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients with ASA classification I-III,
- Aged 20-100 years,
- scheduled for knee arthroplasty under spinal anaesthesia
Who cannot take part
- Take anticoagulant therapy,
- Patients who have a history of bleeding diathesis,
- have a History of chronic pain before surgery,
- cannot assess their pain (dementia),
- have an infection in the area
- have Multiple trauma,
- have been operated on under general anaesthesia,
- do not accept the procedure
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Effect of Erector Spinae Plane Block and iPACK block with Adductor Canal Block on pain management, and NLR and PLR following knee arthroplasty
The 3 groups in the trial
- PlaceboPlacebo, for comparison
Only spinal anaesthesia - No peripheral nerve block
Treatment: Control Test - spinal anesthesia
- Erector Spinae Plane BlockExisting treatment, for comparison
spinal anaesthesia and unilateral ultrasound guided erector spinae plane block - 20ml 0.2% ropivacaine
Treatment: Ropivacaine 0.2% Injectable Solution ESPB
- Infiltration Popliteal Artery and Capsule of the Knee and Adductor Canal BlockExisting treatment, for comparison
spinal anaesthesia and ultrasound guided Infiltration of local anesthetic between the Popliteal Artery and Capsule of the Knee (iPACK) block - 20ml 0.2% ropivacaine \+ ultrasound guided Adductor Canal Block - 10ml 0.2% ropivacaine
Treatment: Ropivacaine 0.2% Injectable Solution iPACK+ACB
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 26 September 2024